Lilly USA, LLC Launches New Rotation Program for Medical Students
Tulane University School of Medicine participates in pilot program
INDIANAPOLIS, Feb. 12, 2014
INDIANAPOLIS, Feb. 12, 2014 /PRNewswire/ --Lilly USA, LLC (NYSE: LLY)
announced today the launch of a new rotation program for aspiring physicians.
The rotation assignments cut across different aspects of the pharmaceutical
company's business – from drug discovery and development to bioethics and
patient safety – providing third- and fourth-year medical students a lens into
the pharmaceutical industry, its vision and focus on improving patient
Students from Tulane University School of Medicine will be the first to
participate in the pilot program at Eli Lilly and Company's Indianapolis
"We're excited to kick off the Medical Student Rotation Program," said Yolanda
Johnson-Moton, director of external relations, US Medical Division, Lilly.
"The students selected for this program distinguished themselves, both
academically and during the interview process.
"The program is intensive and exposes these future practitioners to the
various scientific and medical phases of the drug development process, along
with a holistic view of the company. Students have a unique vantage point and
opportunity to work alongside some of the most talented health care
professionals in the industry, including physicians, and understand their
important roles in our organization."
The Medical Student Rotation Program is a four-week experiential learning
program. In partnership with Tulane University School of Medicine, medical
students will gain experience and understanding of drug development and how
physicians at Lilly contribute to the process. The program features a
student-centric curriculum and structured mentorship in various aspects of
pharmaceutical development. This includes independent projects, industry-led
workshops, exposure to many facets of drug discovery and development and
networking opportunities with Lilly medical leaders.
"Students participating in the program will get hands-on knowledge of the many
roles physicians play in the pharmaceutical industry," said Dr. Marc J. Kahn,
senior associate dean for admissions and student affairs at Tulane University
School of Medicine. "The partnership between Lilly and Tulane matches Lilly's
commitment to medical education with Tulane's passion for providing exciting
educational experiences for our students. Tulane has the largest combined
MD/MPH program in the country, a successful MD/MBA program and a program in
medical innovation. This experience combined with Lilly's reputation as a
leader in the pharmaceutical industry makes the partnership a natural one."
About Tulane University School of Medicine
One of the nation's most recognized centers for medical education, Tulane
University School of Medicine is a vibrant center for education, research and
public service. Tulane School of Medicine is the second-oldest medical school
in the Deep South and the 15th oldest medical school in the United States.
Tulane School of Medicine recruits top faculty, researchers and students from
around the world, and pushes the boundaries of medicine with groundbreaking
medical research and surgical advances. Tulane remains in the forefront of
modern medical innovation and is equipping the next generation of medical
professionals with the tools to succeed in the rapidly changing future of
About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make
life better for people around the world. We were founded more than a century
ago by a man committed to creating high-quality medicines that meet real
needs, and today we remain true to that mission in all our work. Across the
globe, Lilly employees work to discover and bring life-changing medicines to
those who need them, improve the understanding and management of disease, and
give back to communities through philanthropy and volunteerism. To learn more
about Lilly, please visit us at www.lilly.com and
Refer to: (317) 651-1494; firstname.lastname@example.org - J. Scott MacGregor, Lilly
(317) 631-6400; email@example.com - Kelly Hoffman, Borshoff
SOURCE Eli Lilly and Company
Press spacebar to pause and continue. Press esc to stop.